サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：気管支拡張薬の世界市場規模調査＆予測：適応症別（喘息、慢性閉塞性肺疾患、その他）、薬剤タイプ別、投与経路別、地域別分析、2022-2029年
市場調査レポート
商品コード
1261218

気管支拡張薬の世界市場規模調査＆予測：適応症別（喘息、慢性閉塞性肺疾患、その他）、薬剤タイプ別、投与経路別、地域別分析、2022-2029年

Global Bronchodilators Market Size study & Forecast, by Indication (Asthma, Chronic obstructive pulmonary disease, Others), by Drug Type, by Route Of Administration and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
気管支拡張薬の世界市場規模調査＆予測：適応症別（喘息、慢性閉塞性肺疾患、その他）、薬剤タイプ別、投与経路別、地域別分析、2022-2029年
出版日: 2023年04月17日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

気管支拡張剤の世界市場は、2021年に約337億8,000万米ドルと評価され、予測期間2022-2029年には5.2％以上の健全な成長率で成長すると予測されています。

気管支拡張剤は、肺（気管支）気道の通路の筋肉を弛緩させ、呼吸を楽にするために広げる薬剤の一種です。肺の中の空気の流れを良くし、気道の抵抗を少なくします。さらに、気管支拡張剤は、肺の粘液を少なくするために利用されます。これらの薬剤は、呼吸器疾患の患者さんが吸入器やネブライザーを使って服用します。吸入用気管支拡張剤は、さらに粘液クリアランスにも影響を及ぼします。肺の筋肉を弛緩させ、気道を拡大することにより、気管支拡張剤は閉塞性肺疾患（気管支）の治療に採用されています。肺疾患の治療に関する意識の高まり、老年人口の増加、喫煙者数の増加が、全世界の市場需要を促進している主な要因です。

肺疾患の有病率の上昇は、世界市場成長の主要な促進要因として作用しています。例えば、世界保健機関（WHO）は、呼吸器疾患による感染症を第3位の死亡原因としており、年間約300万人（全世界の死亡者数の6％）が死亡しており、COPDによる死亡者の約90％は低・中所得国の70歳以上の人で発生しているとされています。また、喘息は世界で2億6,200万人が罹患していると推定され、その多くは若年層が罹患していると言われています。このように、様々な呼吸器疾患や肺疾患の発生率が高いことが、市場の需要を大きく高めています。さらに、世界の汚染レベルの高まりや、気管支拡張剤に関連する研究開発投資の増加は、予測期間中にさまざまな有利な機会をもたらしています。しかし、気管支拡張剤の副作用や長い承認期間、厳しい規制が、2022-2029年の予測期間を通じて市場成長の妨げとなっています。

気管支拡張剤の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は、COPD、喘息、その他の慢性呼吸器疾患の治療に関する意識の高まりと、政府によるイニシアチブの増加により、収益面で市場を独占しています。一方、アジア太平洋地域は、呼吸器疾患の患者数の多さ、ヘルスケアインフラの改善、医薬品分野における気管支拡張剤の需要増などの要因により、予測期間中に最も高いCAGRで成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントや国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 気管支拡張剤市場、地域別、2019-2029年
    • 気管支拡張剤市場、適応症別、2019-2029年
    • 気管支拡張剤市場、薬剤タイプ別、2019-2029年
    • 気管支拡張剤市場、投与経路別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 気管支拡張剤の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 気管支拡張剤の世界市場力学

  • 気管支拡張剤市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 喫煙者数の増加
      • 肺疾患の有病率の上昇
    • 市場の課題
      • 気管支拡張剤の副作用
      • 長い承認期間と厳しい規制
    • 市場機会
      • 世界の公害の深刻化
      • 気管支拡張剤に関連する研究開発投資の拡大

第4章 気管支拡張剤の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 主な投資機会
  • 主要成功戦略
  • 業界関係者見通し
  • アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 気管支拡張剤の世界市場：適応症別

  • マーケットスナップショット
  • 気管支拡張剤の世界市場：適応症別、実績 - ポテンシャル分析
  • 気管支拡張薬の世界市場、適応症別推定・予測2019-2029
  • 気管支拡張剤市場、サブセグメント分析
    • 気管支喘息
    • 慢性閉塞性肺疾患（COPD）
    • その他

第7章 気管支拡張剤の世界市場：薬剤タイプ別

  • マーケットスナップショット
  • 気管支拡張剤の世界市場：薬剤タイプ別、実績 - ポテンシャル分析
  • 気管支拡張薬の世界市場薬剤タイプ別推定・予測2019-2029
  • 気管支拡張剤市場、サブセグメント分析
    • シンパソミメティックス
    • 抗コリン剤
    • ホスホジエステラーゼ・インヒビター
    • 配合剤

第8章 気管支拡張薬の世界市場：投与経路別

  • マーケットスナップショット
  • 気管支拡張剤の世界市場：投与経路別）、実績 - ポテンシャル分析
  • 気管支拡張薬の世界市場、投与経路別推定・予測2019-2029
  • 気管支拡張剤市場、サブセグメント分析
    • オーラル
    • インジェクション
    • 吸入器

第9章 気管支拡張剤の世界市場：地域別分析

  • 気管支拡張剤市場、地域別市場スナップショット
  • 北米
    • 米国
      • 適応症別の推定・予測、2019年～2029年
      • 薬剤タイプ別の推定・予測、2019-2029年
      • 投与経路別の推定・予測、2019年～2029年
    • カナダ
  • 欧州気管支拡張剤市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の気管支拡張剤市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの気管支拡張剤市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第10章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Abbott Laboratories
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • AstraZeneca plc.
    • Boehringer Ingelheim International GmbH
    • GlaxoSmithKline Plc.
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG.
    • Pfizer Inc.
    • SANOFI
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group Plc

第11章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Bronchodilators Market, report scope
  • TABLE 2. Global Bronchodilators Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Bronchodilators Market estimates & forecasts by Indication 2019-2029 (USD Billion)
  • TABLE 4. Global Bronchodilators Market estimates & forecasts by Drug Type 2019-2029 (USD Billion)
  • TABLE 5. Global Bronchodilators Market estimates & forecasts by Route Of Administration 2019-2029 (USD Billion)
  • TABLE 6. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Bronchodilators Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Bronchodilators Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Bronchodilators Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Bronchodilators Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Bronchodilators Market
  • TABLE 71. List of primary sources, used in the study of global Bronchodilators Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Bronchodilators Market, research methodology
  • FIG 2. Global Bronchodilators Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Bronchodilators Market, key trends 2021
  • FIG 5. Global Bronchodilators Market, growth prospects 2022-2029
  • FIG 6. Global Bronchodilators Market, porters 5 force model
  • FIG 7. Global Bronchodilators Market, pest analysis
  • FIG 8. Global Bronchodilators Market, value chain analysis
  • FIG 9. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Bronchodilators Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Bronchodilators Market, regional snapshot 2019 & 2029
  • FIG 15. North America Bronchodilators Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Bronchodilators Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Bronchodilators Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Bronchodilators Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Bronchodilators Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Bronchodilators Market is valued at approximately USD 33.78 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2022-2029. A bronchodilator is a type of drug that relaxes the muscles in the lungs (bronchi) airway passageways and widens them to make breathing easier. They enhance airflow within the lungs and lessen resistance in the respiratory tract. Additionally, bronchodilators are utilized to lessen pulmonary mucus. These medications are taken by patients with respiratory conditions using inhalers or nebulizers. Inhalation bronchodilators additionally influence mucociliary clearance. By relaxing the muscles in the lungs and enlarging the airways, bronchodilators are employed in the treatment of obstructive lung disorders (bronchi). The growing awareness regarding the treatment of lung diseases, increasing geriatric population, coupled with the rise in number of smokers are the primary factors that are fostering the market demand across the globe.

The rising prevalence of lung diseases is acting as a chief driving factor for the growth of the global market. For instance, the World Health Organization (WHO) lists respiratory disease infections as the third leading cause of mortality, accounting for around 3 million deaths per year (or 6% of all fatalities worldwide), with nearly 90% of COPD fatalities occurring in individuals over 70 from low- and middle-income nations. Also, it is estimated that 262 million people worldwide have asthma, which typically affects youngsters. Thus, the high incidences of various respiratory and lung diseases are augmenting the market demand at a substantial rate. Moreover, the heightened pollution levels globally, as well as the growing R&D investments related to bronchodilators are presenting various lucrative opportunities over the forecasting years. However, the adverse effects of bronchodilators and long approval times and stringent regulations are hindering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bronchodilators Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing awareness regarding the treatment of COPD, asthma, and other chronic respiratory disorders, along with the rising number of government initiatives. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the high presence of respiratory disorder patient pool, improving healthcare infrastructure, and rise in demand for bronchodilators in the pharmaceutical sector across the regional market.

Major market players included in this report are:

  • Abbott Laboratories
  • AstraZeneca plc.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline Plc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG.
  • Pfizer Inc.
  • SANOFI
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group Plc

Recent Developments in the Market:

  • In May 2020, Glenmark Pharmaceuticals Ltd. declared that the company has successfully launched its Single Inhaler Triple Therapy (AIRZ-FF) which is a combination of two bronchodilators, namely, Formoterol and Glycopyrronium, and corticosteroid Fluticasone propionate. The product is specially designed for Chronic Obstructive Pulmonary Disease (COPD) patients in India.
  • In October 2020, Zydus Cadila announced that the company received final approval from the United States Food and Drug Administration (USFDA) to trade its Albuterol Tablets (in the strengths of 2 mg and 4 mg) which are used to treat and prevent bronchospasm.

Global Bronchodilators Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Indication, Drug Type, Route Of Administration, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Indication:

  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Others

By Drug Type:

  • Sympathomimetics
  • Anticholinergics
  • Phosphodiesterase Inhibitor
  • Combination Drugs

By Route Of Administration:

  • Oral
  • Injection
  • Inhaler

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Bronchodilators Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Bronchodilators Market, by Indication, 2019-2029 (USD Billion)
    • 1.2.3. Bronchodilators Market, by Drug Type, 2019-2029 (USD Billion)
    • 1.2.4. Bronchodilators Market, by Route Of Administration, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Bronchodilators Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Bronchodilators Market Dynamics

  • 3.1. Bronchodilators Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in number of smokers
      • 3.1.1.2. Rising prevalence of lung diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. Adverse effects of bronchodilators
      • 3.1.2.2. Long approval times and stringent regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Heightened pollution levels globally
      • 3.1.3.2. Growing R&D investments related to bronchodilators

Chapter 4. Global Bronchodilators Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Bronchodilators Market, by Indication

  • 6.1. Market Snapshot
  • 6.2. Global Bronchodilators Market by Indication, Performance - Potential Analysis
  • 6.3. Global Bronchodilators Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
  • 6.4. Bronchodilators Market, Sub Segment Analysis
    • 6.4.1. Asthma
    • 6.4.2. Chronic obstructive pulmonary disease (COPD)
    • 6.4.3. Others

Chapter 7. Global Bronchodilators Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Bronchodilators Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Bronchodilators Market Estimates & Forecasts by Drug Type 2019-2029 (USD Billion)
  • 7.4. Bronchodilators Market, Sub Segment Analysis
    • 7.4.1. Sympathomimetics
    • 7.4.2. Anticholinergics
    • 7.4.3. Phosphodiesterase Inhibitor
    • 7.4.4. Combination Drugs

Chapter 8. Global Bronchodilators Market, by Route Of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Bronchodilators Market by Route Of Administration, Performance - Potential Analysis
  • 8.3. Global Bronchodilators Market Estimates & Forecasts by Route Of Administration 2019-2029 (USD Billion)
  • 8.4. Bronchodilators Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Injection
    • 8.4.3. Inhaler

Chapter 9. Global Bronchodilators Market, Regional Analysis

  • 9.1. Bronchodilators Market, Regional Market Snapshot
  • 9.2. North America Bronchodilators Market
    • 9.2.1. U.S. Bronchodilators Market
      • 9.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Route Of Administration breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Bronchodilators Market
  • 9.3. Europe Bronchodilators Market Snapshot
    • 9.3.1. U.K. Bronchodilators Market
    • 9.3.2. Germany Bronchodilators Market
    • 9.3.3. France Bronchodilators Market
    • 9.3.4. Spain Bronchodilators Market
    • 9.3.5. Italy Bronchodilators Market
    • 9.3.6. Rest of Europe Bronchodilators Market
  • 9.4. Asia-Pacific Bronchodilators Market Snapshot
    • 9.4.1. China Bronchodilators Market
    • 9.4.2. India Bronchodilators Market
    • 9.4.3. Japan Bronchodilators Market
    • 9.4.4. Australia Bronchodilators Market
    • 9.4.5. South Korea Bronchodilators Market
    • 9.4.6. Rest of Asia Pacific Bronchodilators Market
  • 9.5. Latin America Bronchodilators Market Snapshot
    • 9.5.1. Brazil Bronchodilators Market
    • 9.5.2. Mexico Bronchodilators Market
    • 9.5.3. Rest of Latin America Bronchodilators Market
  • 9.6. Rest of The World Bronchodilators Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Abbott Laboratories
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. AstraZeneca plc.
    • 10.2.3. Boehringer Ingelheim International GmbH
    • 10.2.4. GlaxoSmithKline Plc.
    • 10.2.5. F. Hoffmann-La Roche Ltd.
    • 10.2.6. Novartis AG.
    • 10.2.7. Pfizer Inc.
    • 10.2.8. SANOFI
    • 10.2.9. Teva Pharmaceutical Industries Ltd.
    • 10.2.10. Vectura Group Plc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption